Alexander Hovard Sparre-ulrich

Title: Alexander Hovard Sparre-ulrich: Innovator in Peptide Analogues

Introduction

Alexander Hovard Sparre-ulrich is a notable inventor based in Copenhagen, Denmark. He has made significant contributions to the field of peptide analogues, particularly in the development of glucose-dependent insulinotropic peptide (GIP) derivatives. His work has implications for improving pharmacokinetic profiles and antagonistic activity in medical applications.

Latest Patents

Sparre-ulrich holds 2 patents related to modified GIP peptide analogues. These patents disclose GIP-derived peptide analogues that act as antagonists of the GIP receptor. The modifications include one or more individual amino acid substitutions, and the peptides are fatty acid conjugated with or without a linker. This innovative approach aims to enhance the antagonistic activity and improve the pharmacokinetic profile of these peptides.

Career Highlights

Throughout his career, Alexander Hovard Sparre-ulrich has worked with prominent organizations such as Antag Therapeutics Aps and the University of Copenhagen. His experience in these institutions has allowed him to advance his research and contribute to the scientific community.

Collaborations

Sparre-ulrich has collaborated with notable colleagues, including Bjørn Behrens Sivertsen and Ditte Riber. These partnerships have fostered a collaborative environment that enhances the research and development of peptide analogues.

Conclusion

Alexander Hovard Sparre-ulrich is a distinguished inventor whose work in modified GIP peptide analogues has the potential to impact medical science significantly. His contributions and collaborations continue to advance the field of peptide research.